CD28 and chronic myelogenous leukemia, BCR-ABL1 positive: For the ex vivo analyses, the CD8+ and CD4+ T cells were stimulated with anti-CD3, anti-CD28, and anti-CD49d antibodies and NK cells with CML cell line K562 (gating strategies in Supplemental Figure 6, A–C).